Table 3.
Patient's clinical outcomes.
| All Patients (n = 1468) /Denominator | 28-day non-survivors (n = 540) | 28-day survivors (n = 928) | p-value | |
|---|---|---|---|---|
| ICU Mortality at 28 days, n ( %) | 540 (36.8) | |||
| 90-day mortality, n ( %) | 600 (40.9) | |||
| Discharge from ICU alive, n ( %) | 869 (59.1) | |||
| Discharged from hospital alive, n ( %) | 757 (51.6) | |||
| Transfer to another institution, n ( %) | 94 (6.5) | |||
| Mortality Subgroup analysis according to time of death | ||||
| 0–28 days, n ( %) | 540 (90.05) | |||
| 29–60 days, n ( %) | 54(8.9) | |||
| 61–90 days, n ( %) | 6 (0.06) | |||
| ICU length of stay (days), Median (IQR) | 9 (5–16)/1468 | 10 (5–16) | 9 (5–17) | 0.356 |
| Hospital length of stay, (days) Median (IQR) | 15 (9–24)/1468 | 13 (7–18) | 18 (11–31) | < 0.001 * |
| Mechanical ventilation duration (days) Median (IQR) | 7 (0–14)/1082 | 10 (4–15) | 3 (0–11) | < 0.001 * |
| Infection (positive culture, respiratory), n ( %) | 227 (33.4)/679 | 131 (46.6) | 96 (24.1) | < 0.001 * |
| Infection (positive culture, blood), n ( %) | 267 (24.3)/1100 | 151 (34.2) | 116 (17.6) | < 0.001 * |
| AKI requiring RRT, n ( %) | 178 (14.1)/1259 | 130 (28.6) | 48 (6) | < 0.001 * |
| Pneumothorax, n ( %) | 89 (6.2)/1440 | 55 (10.4) | 34 (3.7) | < 0.001 * |
| Myocardial infarction, n ( %) | 64 (4.5)/1433 | 40 (7.6) | 24 (2.6) | < 0.001 * |
| GI Bleeding, n ( %) | 52 (3.6)/1438 | 27 (5.1) | 25 (2.7) | 0.019 * |
| Pulmonary embolism, n ( %) | 44 (3.1)/1435 | 20 (3.8) | 24 (2.6) | 0.215 |
| Deep vein thrombosis, n ( %) | 33 (2.3)/1435 | 17 (3.2) | 16 (1.8) | 0.070 |
| Intracranial hemorrhage, n ( %) | 33 (2.3)/1432 | 15 (2.9) | 18 (2) | 0.277 |
| Ischemic Stroke, n ( %) | 32 (2.2)/1438 | 14 (2.7) | 18 (2) | 0.39 |
AKI, acute kidney injury ICU, intensive care unit. GI, gastrointestinal. RRT, renal replacement therapy.